Education
About Us
Working with TipRanks
Follow Us
Daniel Spiegelman Insider Profile
11 Followers
Daniel Spiegelman, EVP & CFO at BioMarin Pharmaceutical, holds 32.92K shares in Myriad Genetics (Ticker: MYGN), holds 47.69K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds ― shares in Spruce Biosciences (Ticker: SPRB).
Daniel Spiegelman BioMarin Pharmaceutical (BMRN)EVP & CFO
BioMarin Pharmaceutical (BMRN)
EVP & CFO
Ranked #88,715 out of 105,481 Corporate Insiders
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
-22.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Spiegelman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 10, 2015 - Feb 10, 2016
Return:+29.20%
The most profitable trade made by Daniel Spiegelman
Daniel Spiegelman's Trading History
BioMarin Pharmaceutical
Jun 07, 2019
EVP & CFO
Uninformative Buy
12.11K
$2.88M
Myriad Genetics
Jun 04, 2024
Director
Uninformative Sell
167.01K
$215.94K
Spruce Biosciences
―
Director
―
―
vTv Therapeutics
―
Director
―
―
Kyverna Therapeutics, Inc.
Jun 02, 2025
Director
Uninformative Buy
―
$140.56K
Maze Therapeutics, Inc.
―
Director
―
―
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Relypsa Inc
Jun 23, 2016
―
Uninformative Buy
―
$71.98K
Affymax
―
Director
―
―
Anthera Pharmaceuticals
―
Director
―
―
Bio Green Med Solution
―
Director
―
$0.00
Omeros
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Daniel Spiegelman's performance on stock
You May Also Like
Daniel Spiegelman insider profile FAQ
What is the percentage of profitable transactions made by Daniel Spiegelman?
The percentage of profitable transactions made by Daniel Spiegelman is 57%.
What is the average return per transaction made by Daniel Spiegelman?
The average return per transaction made by Daniel Spiegelman is -22.70%.
What stocks does Daniel Spiegelman hold?
Daniel Spiegelman holds: BMRN, MYGN, SPRB, VTVT, KYTX, MAZE, CASC, RLYP, AFFY, ANTH, BGMS, OMER stocks.
What was Daniel Spiegelman’s latest transaction?
Daniel Spiegelman latest transaction was an Uninformative Sell of $167.01K.
What was Daniel Spiegelman's most profitable transaction?
Daniel Spiegelman’s most profitable transaction was an Informative Sell of BMRN stock on February 10, 2015. The return on the trade was 29.20%.
What is Daniel Spiegelman's role in BioMarin Pharmaceutical?
Daniel Spiegelman's role in BioMarin Pharmaceutical is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.